Our experienced team of global Healthcare, Life Sciences & Chemicals lawyers is complemented by cross-practice specialists who provide advice on the rapidly developing cannabis market across intellectual property, regulatory compliance, investigations, and litigation.

The liberalization of the cannabis market in North America presents a rapidly growing industry with new and exciting opportunities for businesses. While not advancing at the same speed or with equivalent freedoms, the European Union is also beginning to consider more limited acceptance of cannabis-derived products, especially in the medicinal field. Regulations and legal frameworks governing cannabis and its derivatives are undergoing significant debate, amendment, and evolution as governments and the industry seek to refine and exploit the opportunities and benefits available to end-users. Existing legislation is transitioning from a blanket prohibition on activities to relaxing and implementing new rules for various industrial uses and applications, encompassing a range of products such as medicinal, food, cosmetics, and specialty smoking products.

In this dynamic and evolving market, The Arch International advises and guides its clients through the changing and complex legal and regulatory landscape. Their sector approach, coupled with geographic coverage, ensures that their lawyers possess a profound understanding of the diverse regulatory and commercial challenges businesses face when entering different markets worldwide with their cannabis-derived products.

We are uniquely positioned to offer practical and specialized advice to businesses both entering and planning to enter this exciting new market.